Ketamine analogues for treatment of thrombocytopenia
US5250732A · kind A · utility
45Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 1991 |
| Grant date | Oct 5, 1993 |
| Priority date | — |
| Expiry date | Jul 18, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
5,6-Dehydronorketamine and derivatives retaining the .alpha.,.beta.-unsaturated carbonyl are disclosed. These and other Michael or Michael-type acceptors and adducts are shown to influence the replication, differentiation or maturation of blood cells, especially platelet progenitor cells. Accordingly, these compounds are used for treatment of thrombocytopenia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.